Immunohistochemistry tests in Dubai & UAE

Compare available Immunohistochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

450.00–3,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Immunohistochemistry test prices

Showing 16–30 of 89 matching tests.

Immunohistochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2002 Cytokeratin 7 (CK‑7) Immunohistochemistry Test This diagnostic test evaluates the presence and distribution of Cytokeratin 7 protein in tissue samples.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block / Archival Biopsy Slides	5-7 business days	450.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Cytokeratin 7 protein expression"] Parameters [] Preparation ["No fasting required", "Provide biopsy report, exact site, and clinical history"] Indications ["Cancer of unknown primary", "Sub-classification of lung adenocarcinomas", "Differentiation of adenocarcinoma origins"] Measurement technique Confirm with laboratory Codes LOINC: 21528-3 ICD-10: C80.1 Clinical summary This diagnostic test evaluates the presence and distribution of Cytokeratin 7 protein in tissue samples.
TEST-1865 Cytokeratin-20 (CK-20) Immunohistochemistry Test This test detects the presence and distribution of the CK-20 protein in tissue samples to aid in cancer diagnosis and classification.	Formalin-fixed paraffin-embedded (FFPE) tissue block or archival biopsy slide	5–7 working days	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CK-20 protein expression"] Parameters [] Preparation ["No dietary or medication restrictions prior to biopsy."] Indications ["Diagnosis of metastatic carcinoma", "Identification of primary tumour origin", "Cancer of unknown primary workup"] Measurement technique Confirm with laboratory Codes LOINC: 33917-1 ICD-10: C80.1 Clinical summary This test detects the presence and distribution of the CK-20 protein in tissue samples to aid in cancer diagnosis and classification.
TEST-1994 Galectin-3 Immunohistochemistry Test This test evaluates the expression level of the galectin-3 protein within tumor tissue using immunohistochemistry.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block / Archival Biopsy Specimen	5-7 working days	450.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Galectin-3 protein expression"] Parameters [] Preparation ["No fasting required", "Provide histopathology report, biopsy site details, and clinical history"] Indications ["Cancer prognosis", "Therapeutic stratification"] Measurement technique Confirm with laboratory Codes LOINC: 94411-8 ICD-10: C80.1 Clinical summary This test evaluates the expression level of the galectin-3 protein within tumor tissue using immunohistochemistry.
TEST-2026 Glutamine Synthetase Immunohistochemistry (GS IHC) Test This diagnostic test evaluates the presence and expression level of the glutamine synthetase enzyme within liver tissue samples.	Archival Tissue (Formalin-Fixed Paraffin-Embedded Block)	5–7 working days	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Glutamine Synthetase enzyme expression", "Hepatocellular Carcinoma biomarker"] Parameters [] Preparation [] Indications ["Confirmation of hepatocellular carcinoma", "Differentiation of liver lesion subtypes", "Guiding therapeutic decisions"] Measurement technique Confirm with laboratory Codes LOINC: 34504-3 ICD-10: C22.0, D13.4 Clinical summary This diagnostic test evaluates the presence and expression level of the glutamine synthetase enzyme within liver tissue samples.
TEST-2000 Glycophorin A Immunohistochemistry (IHC) Test This diagnostic test evaluates the presence and expression level of the Glycophorin A (CD235a) protein in tissue samples.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Unstained Biopsy Slides	5–7 business days	450.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Glycophorin A (CD235a) protein expression", "Erythroid lineage cell differentiation"] Parameters [] Preparation ["No special patient preparation is needed prior to tissue collection."] Indications ["Confirmation of acute erythroid leukemia", "Differentiation of myeloid disorders with erythroid proliferation", "Distinguishing erythroid predominance in hematologic malignancies"] Measurement technique Confirm with laboratory Codes LOINC: 21908-3 ICD-10: C94.0 Clinical summary This diagnostic test evaluates the presence and expression level of the Glycophorin A (CD235a) protein in tissue samples.
TEST-2003 HHV-8 (LNA-1) Immunohistochemistry (IHC) Test This diagnostic test evaluates formalin-fixed paraffin-embedded tissue for the presence of Human Herpesvirus 8 (HHV-8) latent nuclear antigen-1 (LNA-1) protein.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Slides (Archival Specimen)	5–7 working days	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HHV-8 LNA-1 protein"] Parameters [] Preparation [] Indications ["Diagnosis of Kaposi sarcoma", "Diagnosis of primary effusion lymphoma", "Diagnosis of multicentric Castleman disease", "Evaluation of HHV-8 associated conditions"] Measurement technique Confirm with laboratory Codes LOINC: 74917-0 ICD-10: C46.9 Clinical summary This diagnostic test evaluates formalin-fixed paraffin-embedded tissue for the presence of Human Herpesvirus 8 (HHV-8) latent nuclear antigen-1 (LNA-1) protein.
TEST-2045 IDH1 Mutation Immunohistochemistry Test This test detects the presence of the IDH1 R132H mutant protein in formalin-fixed paraffin-embedded (FFPE) tumor tissue.	Archival Tissue Specimen – FFPE tumor block or formalin-fixed biopsy slides	5 days (standard FFPE block) / 7 days (large or complex specimens)	450.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IDH1 R132H mutant protein"] Parameters [] Preparation ["Submit FFPE block or formalin-fixed biopsy with histopathology report, biopsy site, and clinical history."] Indications ["Suspected or confirmed glioma", "Need for glioma classification", "Prognostic assessment", "Therapeutic stratification"] Measurement technique Confirm with laboratory Codes LOINC: 94477-8 ICD-10: C71.9, C71.0, C71.1 Clinical summary This test detects the presence of the IDH1 R132H mutant protein in formalin-fixed paraffin-embedded (FFPE) tumor tissue.
TEST-2010 IgG4 Immunohistochemistry (IHC) Test This test identifies IgG4-positive plasma cells in tissue biopsies to aid in diagnosing IgG4-related disease.	Archival Tissue Specimen (FFPE Block or Biopsy Slides)	5–7 working days	450.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IgG4-positive plasma cells", "Tissue distribution of IgG4"] Parameters [] Preparation ["Provide original histopathology report.", "Provide biopsy site details.", "Provide relevant clinical history."] Indications ["Diagnosis of IgG4-related disease", "Differentiation from other inflammatory or neoplastic conditions"] Measurement technique Confirm with laboratory Codes LOINC: 21952-8 ICD-10: M35.0 Clinical summary This test identifies IgG4-positive plasma cells in tissue biopsies to aid in diagnosing IgG4-related disease.
TEST-1488 IHC Any Single Marker (HER2/neu, C4d, EBER, Ki‑67) Test This test detects the presence and intensity of a single target protein (HER2/neu, C4d, EBER, or Ki‑67) within formalin-fixed paraffin-embedded tissue sections.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Surgical Pathology Slides	3 business days	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HER2/neu protein expression", "C4d deposition", "EBER RNA presence", "Ki‑67 proliferation index"] Parameters [] Preparation ["No fasting required", "No medication changes required"] Indications ["Diagnosis and prognosis of certain cancers (e.g., breast cancer)", "Evaluation of transplant rejection", "Diagnosis of EBV-associated disorders", "Tumour grading and proliferation assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21651-4 ICD-10: Z01.89 Clinical summary This test detects the presence and intensity of a single target protein (HER2/neu, C4d, EBER, or Ki‑67) within formalin-fixed paraffin-embedded tissue sections.
TEST-1478 IHC Extended Panel (>10 Markers) Test This diagnostic test evaluates multiple protein biomarkers in tumor tissue using immunohistochemistry to aid in cancer classification and treatment planning.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Biopsy Slides (Archival Tissue Specimen)	5 working days	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures [">10 protein markers", "Specific antigens in tumor tissue"] Parameters [] Preparation [] Indications ["Cancer subtyping", "Personalized therapeutic strategies", "Determining cancer type and behavior", "Suitability for targeted therapies"] Measurement technique Confirm with laboratory Codes LOINC: 47527-9 ICD-10: C80.1 Clinical summary This diagnostic test evaluates multiple protein biomarkers in tumor tissue using immunohistochemistry to aid in cancer classification and treatment planning.
TEST-2101 IHC TSH Test This diagnostic test evaluates the presence and expression level of Thyroid Stimulating Hormone (TSH) protein within tissue samples.	FFPE Tissue Block or Biopsy Slide	5–7 Business Days	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Thyroid Stimulating Hormone (TSH) protein expression", "Tissue-specific TSH expression"] Parameters [] Preparation ["No special patient preparation is needed."] Indications ["Diagnosis of thyroid malignancies", "Subtyping of thyroid malignancies", "Guidance for therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 34707-6 ICD-10: C73 Clinical summary This diagnostic test evaluates the presence and expression level of Thyroid Stimulating Hormone (TSH) protein within tissue samples.
TEST-1477 Immunohistochemistry (IHC) Breast Cancer Prognostic Panel (ER, PR, HER2/neu, Ki‑67) Test This diagnostic test evaluates the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2/neu), and the proliferation mark...	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Biopsy Slide	6 days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Estrogen Receptor (ER) expression", "Progesterone Receptor (PR) expression", "HER2/neu overexpression", "Ki‑67 proliferation index"] Parameters [{"name": "Estrogen Receptor (ER)", "reference_range": "Allred score 0-8 (0-2 negative, 3-8 positive)"}, {"name": "Progesterone Receptor (PR)", "reference_range": "Allred score 0-8 (0-2 negative, 3-8 positive)"}, {"name": "HER2/neu", "reference_range": "0, 1+ (negative), 2+ (equivocal), 3+ (positive)"}, {"name": "Ki‑67", "reference_range": "Percentage of positive tumour cells"}] Preparation ["A valid DHA-licensed doctor’s prescription is mandatory.", "Inform your doctor about any blood-thinning medications if a biopsy is required."] Indications ["Diagnosis and classification of breast cancer", "Guiding treatment decisions for breast cancer", "Prognosis assessment in breast cancer"] Measurement technique Confirm with laboratory Codes LOINC: 94548-3 ICD-10: C50.9 Clinical summary This diagnostic test evaluates the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2/neu), and the proliferation marker Ki‑67 in breast cancer tissue.
TEST-1469 Immunohistochemistry (IHC) Panel Test This test evaluates protein expression patterns on cancer cells within FFPE tissue to aid in cancer subtyping and treatment selection.	Archival FFPE Tissue Block / Unstained Slides	5–7 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Specific protein antigens on cancer cells", "Protein expression patterns"] Parameters [] Preparation ["Ensure specimen is placed in 10% neutral buffered formalin immediately upon collection.", "Do not discontinue anticoagulants, immunosuppressants, or any prescribed medication without explicit instruction from your treating physician."] Indications ["Cancer subtyping", "Selection of targeted therapies", "Refining prognostic accuracy"] Measurement technique Confirm with laboratory Codes LOINC: 77599-8 ICD-10: C80.1, Z85.9 Clinical summary This test evaluates protein expression patterns on cancer cells within FFPE tissue to aid in cancer subtyping and treatment selection.
TEST-2071 Immunohistochemistry (IHC) Prostate Benign vs Malignant Panel Test This diagnostic assay distinguishes benign prostatic hyperplasia from malignant adenocarcinoma using multi-marker immunohistochemistry and DNA analysis.	Archival Tissue Specimen (FFPE Tissue Block or Biopsy Slides)	Block: 5 days; Complex tissue: 7 days	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Protein markers (e.g., AMACR, basal cell markers)", "DNA fragment/STR analysis (Loss of heterozygosity, microsatellite instability)", "Morphological assessment (Hematoxylin & Eosin)"] Parameters [] Preparation ["No fasting required", "No medication changes required unless advised by urologist", "Provide histopathology report, biopsy site, and clinical history", "Sample required: FFPE tissue block or slides preserved in 10% formalin"] Indications ["Differential diagnosis of prostate lesions", "Confirmation of malignancy in biopsy specimens", "Assessment of high-grade prostatic intraepithelial neoplasia (PIN)", "Guiding targeted urological interventions"] Measurement technique Confirm with laboratory Codes LOINC: 57830-6 ICD-10: C61, D29.1, Z80.42 Clinical summary This diagnostic assay distinguishes benign prostatic hyperplasia from malignant adenocarcinoma using multi-marker immunohistochemistry and DNA analysis.
TEST-1803 Immunohistochemistry (IHC) Test This diagnostic test evaluates key protein biomarkers (ER, PR, HER2, Ki-67) in breast tumor tissue using digital image analysis.	FFPE tumor block or 10% formalin-fixed biopsy tissue	5–7 business days	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Estrogen Receptor (ER)", "Progesterone Receptor (PR)", "HER2 oncoprotein", "Ki-67 proliferation marker"] Parameters [{"name": "Estrogen Receptor (ER)", "reference_range": "0–3+ score"}, {"name": "Progesterone Receptor (PR)", "reference_range": "0–3+ score"}, {"name": "HER2 oncoprotein", "reference_range": "0–3+ score"}, {"name": "Ki-67 proliferation marker", "reference_range": "Quantifiable percentage"}] Preparation ["Submit formalin-fixed paraffin-embedded (FFPE) tumor block or 10% neutral buffered formalin-fixed biopsy tissue.", "Accompany sample with a copy of the histopathology report and clinical history."] Indications ["Diagnosis of breast cancer", "Treatment planning for breast cancer", "Prognosis assessment in breast cancer"] Measurement technique Confirm with laboratory Codes LOINC: 85319-2 ICD-10: C50.9 Clinical summary This diagnostic test evaluates key protein biomarkers (ER, PR, HER2, Ki-67) in breast tumor tissue using digital image analysis.

Category overview

Immunohistochemistry: overview

Achieving a definitive, targeted diagnosis for suspected malignancies or severe inflammatory conditions requires literally highlighting the disease markers hidden within your tissue. As a foundational diagnostic tool in our Histology department, Immunohistochemistry (IHC) utilizes specialized fluorescent or colored antibodies that bind directly to specific disease-related proteins in a biopsied sample. Utilizing cutting-edge microscopic technology, this vital cellular screening helps precisely classify tumors, detect hidden infections, and evaluate prognostic markers, providing the definitive data necessary to safely guide life-saving precision medicine, specialized oncology treatments, and proactive medical management. Consistently ranked among the premier diagnostic labs in the UAE for tissue analysis, DNA Labs guarantees strict patient confidentiality, exceptional diagnostic accuracy, and incredibly efficient reporting. Take an empowered step toward targeted treatment—book your immunohistochemistry testing in UAE, arrange a secure clinical sample collection, or connect with our dedicated medical specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.